IBM’s Quantum Foundry Secures a $1 Billion U.S. Award

IBM’s Anderon subsidiary has finalized a $1 billion award from the U.S. Department of Commerce to expand domestic manufacturing of quantum-computing wafers, the companies announced Wednesday, September 16, 2026. IBM says the award will support research and development at a 300-millimeter pure-play quantum wafer foundry in Albany, New York. The company is contributing another $1 billion of its own investment. [1][2]

The deal converts a May letter of intent into a formal funding agreement. It also gives the United States a dedicated manufacturing platform for superconducting quantum components, rather than relying solely on university laboratories, prototype lines or foreign suppliers. Anderon is structured as a separate IBM company intended to serve a wider ecosystem of quantum-computing developers, including firms that do not build their own fabrication facilities.

What changed

The immediate change is institutional as much as financial. Quantum hardware companies have generally focused on building complete machines, while semiconductor manufacturers have supplied components through conventional processes that are not always optimized for fragile quantum devices. A dedicated foundry could standardize wafer production, improve repeatability and let researchers iterate on designs without building a new fabrication pipeline for every experiment.

That does not mean Anderon is already producing commercial-scale quantum processors. The award is aimed at research and development, and the company’s manufacturing capabilities still need to be expanded and validated. The technical challenge is substantial: quantum devices must be fabricated with extreme uniformity, integrated with control electronics and operated inside systems that preserve delicate quantum states.

Independent coverage described the award as part of a broader Commerce Department effort to deploy roughly $2 billion across nine quantum-computing companies, with IBM receiving the largest announced allocation. That portfolio approach suggests Washington is funding several competing hardware architectures rather than betting on one route to fault-tolerant machines. [3]

Why it matters

The announcement moves quantum policy from research support toward industrial strategy. A functioning domestic foundry could become shared infrastructure for an emerging sector, lowering the cost of experimentation and helping U.S. companies retain control over critical manufacturing knowledge. It also gives IBM a strategic position between government-funded research and the private companies that may eventually need quantum wafers at scale.

The broader wager is that manufacturing capacity must arrive before quantum applications are commercially proven. That reverses the usual technology-investment sequence: instead of waiting for demand to justify factories, the government and IBM are building capacity in anticipation of demand. The approach resembles earlier semiconductor policy, but quantum economics remain much less certain.

What remains uncertain

The central question is utilization. Quantum computing has not yet demonstrated broad, reliable advantages over classical systems in most commercial workloads. Anderon will need customers, repeatable processes and designs that can move beyond laboratory conditions. It is also unclear how quickly different quantum architectures will converge on shared manufacturing requirements.

For now, the award is best understood as an infrastructure bet, not proof that useful quantum computing has arrived. Its success will depend on whether a foundry can turn public capital and IBM’s expertise into a scalable supply chain before the technology’s application market is fully formed.